Osteoactivin Protein - ACROBiosystems

Home
Products

Products by Category

Recombinant proteins and more
Multi-pass Transmembrane Proteins and Technology PlatformsNew FDA DMF Filed ProteinsHot SARS-CoV-2 Related ProductsHot Immune Checkpoint ProteinsHot Targets of CAR-T Cell TherapyNew CytokinesHot Biosimilar Drug TargetsHot Tumor MicroenvironmentHot Anti-idiotypic AntibodyHot Fc Receptor Proteins Llama IgG Fc Fusion ProteinNew Bio-Markers & CD Antigens ActiveMax -Best Cytokines Viral Proteins Enzymes Antibodies All Recombinant Proteins

Pre-labeled proteins
CAR rapid detection reagentsNew Biotinylated protein collectionHot FITC & PE labeled ProteinsNew Fluorescent fusion proteins
Kits
SARS-CoV-2 Related Kit ProductsNew Pre-Coupling Magnetic BeadsNew ELISA Assay Kits for Quantitative Analysis of Therapeutic Antibodies in Serum Samples Inhibitor Screening Kits
Others
HPLC-verified Proteins Integrin - Integrin Proteins BCMA - B-Cell Maturation Antigen TIGIT - TIGIT Signaling Axis CD24 & Siglec-10 proteinsHot

Hot Products

Supports on COVID-19 R&D
Reagents for vaccine developmentNew Reagents for diagnostic developmentNew SARS-CoV-2 related productsNew SARS-CoV-2 related kitsNew SARS-CoV-2 mutant productsNew
Others
Multi-pass Transmembrane Proteins and Technology PlatformsNew Claudin18.2 ProteinsNew Bispecific antibody targetsHot Targets for ADCsHot IL-2 ReceptorsHot CD19 proteinsHot Anti-FMC63 mAbHot CD3 proteinsHot B7 family proteinsHot TNFSF proteinsHot VEGF proteinsHot CD39/CD73 proteinsNew Siglec-15 proteinsHot CD20 proteinsExclusive PD1 proteinsHot
Services

Innovation Lab
SPR /BLI analytical serviceNew Anti-Idiotypic AntibodyNew Enzyme-Linked Immunosorbent Assay (ELISA) Service New
Licensing Opportunities
Anti-TIM-3 monoclonal antibody New Anti-LAG-3 monoclonal antibody New Target 4-1BB monoclonal antibody New
Supports

How to Order Shipping & Payments Global Distributors Testimonials Download Brochures Download COA
Applications

The Process of How SARS-CoV-2 Infects the Host Quantitative Analysis of mAb in Serum Evaluation of CAR Expression
Company

About Us Join Us Contact Us
Activities

News Exhibitions Promotion
COVID-19 R&D ^New

Osteoactivin

Brief Information

Name:Transmembrane glycoprotein NMB
Target Synonym:Transmembrane Glycoprotein,HGFIN,Hematopoietic growth factor inducible neurokinin-1 type,GPNMB,Glycoprotein Nmb,Hematopoietic Growth Factor Inducible Neurokinin-1,Glycoprotein Nonmetastatic Melanoma Protein B,Transmembrane Glycoprotein HGFIN,Glycoprotein

Number of Launched Drugs:0
Number of Drugs in Clinical Trials:1
Lastest Research Phase:Phase 2 Clinical


GPB-H5229	Human	Human Osteoactivin / GPNMB Protein, His Tag

Cat. No.

Species

Product Description

Structure

Purity

Feature

GPB-H5229

Human

Human Osteoactivin / GPNMB Protein, His Tag

Synonym Name

GPNMB,HGFIN,NMB,Osteoactivin

Background

Transmembrane glycoprotein NMB (GPNMB) is also known as Transmembrane glycoprotein HGFIN, DC-HIL and Osteoactivin (OA), which belongs to the PMEL/NMB family. GPNMB contains one PKD domain. GPNMB is a transmembrane glycoprotein that is up-regulated in various cancer cells, including in glioblastoma multiforme and is expressed in many melanoma cells, as well as in tissue macrophages. GPNMB protein acts as a downstream mediator of BMP-2 effects on osteoblast differentiation and function. GPNMB participates in bone mineralization, and functions as a negative regulator of inflammation in macrophages.

Clinical and Translational Updates

Clinical Drug Information

Name	Research Code	Research Phase	Company	Indications	Clinical Trials
Glembatumumab vedotin	CR-011; CDX-011; CR-011-ADC; CR011-vcMMAE	Phase 2 Clinical	Celldex	Triple Negative Breast Neoplasms; Osteosarcoma; Breast Neoplasms; Carcinoma, Squamous Cell; Melanoma	Details